# BIGDP2026.6 — Phase 7 Dry-Run Results

**Project:** PROJECT_042 — 安徽巨目 (Refracto-Keratometer, Class IIa)
**Date:** 2026-06-08
**Type:** Code-path verification with project data shape (limited dry-run)
**Full pipeline run:** PENDING (requires DeerFlow intake pipeline execution)

---

## Pre-Run Verification

```bash
bash BIGDP2026_6/deploy_verify.sh
```
**Result:** ALL 25 CHECKS PASSED ✅

---

## Code-Path Verification (Limited Dry-Run)

Since the full DeerFlow authoring pipeline requires the intake pipeline to process raw manufacturer data first, this dry-run verifies the BIGDP2026.6 code paths with a synthetic state that mirrors PROJECT_042's device characteristics.

### Device Profile (synthetic, based on project data)

| Field | Value |
|:---|:---|
| Device Name | Refracto-Keratometer AR(K)-1 |
| Device Class | IIa |
| Intended Use | Automated refraction and keratometry measurement for ophthalmic examination |
| Clinical Domain | ophthalmology_diagnostics |
| Target Population | Adult and pediatric patients requiring vision assessment |
| Mechanism of Action | Infrared light reflection and analysis for corneal curvature and refractive error measurement |

### Test Execution

```bash
.venv/bin/python3 -m pytest backend/packages/harness/deerflow/runtime/cer_authoring/tests/ -q
```
**Result:** 500 passed, 0 failed ✅

### Ledger Node Verification

All 3 ledger nodes produce valid output with ophthalmic device characteristics:

```
CER_REASONING_LEDGER: 3 claims generated
  - C-01 (clinical_performance): conclusion_strength=strong, gap=no_gap
  - C-02 (clinical_safety): conclusion_strength=moderate, gap=PMCF
  - C-03 (usability): conclusion_strength=limited, gap=PMCF

IFU_CLAIM_EVOLUTION_LEDGER: 3 claims tracked through 5 stages
BENCHMARK_DERIVATION_TRACE: 2 endpoints with acceptability rationale
```

### G46 Writer Release Board

All conditions verified with ophthalmic device context:
- `claim_evidence`: PASS ✅
- `retrieval_completeness`: PASS ✅
- `SOTA`: PASS ✅
- `BR`: PASS ✅
- `alignment`: PASS ✅
- `CER_REASONING_LEDGER`: PASS ✅
- `IFU_CLAIM_EVOLUTION_LEDGER`: PASS ✅
- `BENCHMARK_DERIVATION_TRACE`: PASS ✅

### Benchmark Domain

Ophthalmology diagnostics is NOT in the known domain list. Generic fallback applied:
- `directness: fallback`
- `confidence: low`
- `limitations: ["No source studies available for benchmark derivation."]`
- `acceptability_rationale: "No benchmark data available — CER must note this limitation."`

This correctly demonstrates the benchmark generalization feature (Phase 5/R4).

---

## Expert Logic Verification

### Proof 1: Weak evidence → not strong ✅
- `indirect + 3 studies → moderate` (capped, not strong)
- `manufacturer + 1 study → limited` (capped, not moderate)

### Proof 2: IFU overclaim detection ✅
- Marketing language: "guarantees perfect results" → `flag_marketing_language`
- Evidence-insufficient claim → `reject_from_cer`

### Proof 3: Fallback benchmark limitation ✅
- Alternative therapy + 1 study → `fallback/low`
- 0 studies → `fallback/insufficient`

---

## Remaining for Full Pipeline Dry-Run

The following steps require the Controller to execute with the full DeerFlow pipeline:

1. Run intake pipeline on PROJECT_042 raw data → produce `device_profile`, `claim_ledger`, etc.
2. Run authoring pipeline (`run_cer_authoring.py`) → execute full DAG including ledger nodes
3. Verify `CER_INPUT_PACKAGE.json` contains all 3 ledgers with non-placeholder data
4. Run `writer_package_validator.py` on the exported package
5. Compare output against pre-upgrade baseline (if available)

### Full Pipeline Run Command
```bash
cd /Users/winstonwei/Documents/Playground/deer-flow
.venv/bin/python3 backend/scripts/run_cer_authoring.py \
  --project <project_dir> \
  --artifact-root <project_dir>/artifacts
```

---

## Conclusion

**Code-path dry-run: PASS.** All BIGDP2026.6 code paths verified with PROJECT_042 data shape. 500 tests pass. Deploy script: 25/25 checks pass. The system is ready for full pipeline dry-run. The generic fallback benchmark correctly handled the unknown ophthalmology domain — exactly the Phase 5 generalization behavior.

**Full pipeline dry-run: PENDING.** Requires Controller to execute intake + authoring pipeline with PROJECT_042 raw data.
